Lifeward gets 180-day Nasdaq bid-price extension to Aug 3, 2026; 1-for-12 reverse split approved

Lifeward Ltd.

Nasdaq gave Lifeward 180-day extension until Aug 3, 2026 to meet $1.00 bid price rule.
Company failed to regain compliance by Feb 2, 2026 initial deadline; deficiency letter Aug 5, 2025.
Shareholders approved reverse split up to 1-for-12 in Jan 2026; board controls timing.
Company may use reverse split to boost share price but no guarantee of compliance.
If not compliant by Aug 3, 2026, Nasdaq will start delisting process; appeal possible.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.